We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
-17.1%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.69B
AUM Growth
-$1.36B
(-19%)
Cap. Flow
-$72.7M
Cap. Flow
% of AUM
-1.28%
Top 10 Holdings %
Top 10 Hldgs %
17.58%
Holding
1,139
New
165
Increased
376
Reduced
380
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$58.3M |
| 2 |
CELG
Celgene Corp
CELG
|
+$27.6M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$23.3M |
| 4 |
TJX Companies
TJX
|
+$23.1M |
| 5 |
Synopsys
SNPS
|
+$19.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dell
DELL
|
+$45.2M |
| 2 |
Rockwell Automation
ROK
|
+$25.3M |
| 3 |
Accenture
ACN
|
+$24M |
| 4 |
Visteon
VC
|
+$23.4M |
| 5 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$22.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.85% |
| 2 | Financials | 17.71% |
| 3 | Consumer Discretionary | 12.6% |
| 4 | Healthcare | 11.49% |
| 5 | Industrials | 11.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NSTG
726
DELISTED
NanoString Technologies, Inc.
NSTG
| $514K | 0.01% |
34,626
-24,947
| -42% | -$396K |
|
|
LEAF
727
DELISTED
Leaf Group Ltd.
LEAF
| $510K | 0.01% |
74,394
-3,900
| -5% | -$33.5K |
|
728
Idacorp
IDA
$8.23B
| $507K | 0.01% |
5,450
+150
| +3% | +$14.6K |
|
|
FPRX
729
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $506K | 0.01% |
54,447
| – | – |
|
730
Merchants Bancorp
MBIN
$2.19B
| $500K | 0.01% |
37,542
+1,566
| +4% | +$23.5K |
|
731
WEX
WEX
$6.11B
| $499K | 0.01% |
+3,560
| New | +$586K |
|
732
Prothena Corp
PRTA
$458M
| $496K | 0.01% |
+48,175
| New | +$573K |
|
|
DF
733
DELISTED
Dean Foods Company
DF
| $495K | 0.01% |
+129,800
| New | +$784K |
|
|
QADA
734
DELISTED
QAD Inc.
QADA
| $494K | 0.01% |
12,560
-25,881
| -67% | -$1.13M |
|
|
VAR
735
DELISTED
Varian Medical Systems, Inc.
VAR
| $492K | 0.01% |
4,340
-59,430
| -93% | -$6.8M |
|
736
Digital Turbine
APPS
$1.02B
| $483K | 0.01% |
264,141
-104,794
| -28% | -$165K |
|
737
Forte Biosciences
FBRX
$1.12B
| $482K | 0.01% |
157
-9
| -5% | -$38.8K |
|
|
SRGA
738
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $482K | 0.01% |
4,342
-220
| -5% | -$28.7K |
|
739
BOK Financial
BOKF
$8.64B
| $479K | 0.01% |
6,530
| – | – |
|
740
LifeVantage
LFVN
$82.4M
| $478K | 0.01% |
36,246
| – | – |
|
741
CytomX Therapeutics
CTMX
$705M
| $473K | 0.01% |
31,301
| – | – |
|
742
Quantum Corp
QMCO
$437M
| $472K | 0.01% |
11,794
-310
| -3% | -$14.2K |
|
|
ALDR
743
DELISTED
Alder Biopharmaceuticals
ALDR
| $467K | 0.01% |
45,525
+20,900
| +85% | +$268K |
|
|
ELGX
744
DELISTED
Endologix Inc
ELGX
| $463K | 0.01% |
64,655
+26,702
| +70% | +$297K |
|
745
Coherus Oncology
CHRS
$217M
| $457K | 0.01% |
50,486
-31,725
| -39% | -$367K |
|
|
IVAC
746
DELISTED
Intevac Inc
IVAC
| $457K | 0.01% |
87,402
+5,983
| +7% | +$28.5K |
|
|
EMKR
747
DELISTED
Emcore Corp
EMKR
| $457K | 0.01% |
+10,882
| New | +$510K |
|
|
RTW
748
DELISTED
RTW Retailwinds, Inc.
RTW
| $456K | 0.01% |
+161,087
| New | +$496K |
|
749
Inseego
INSG
$108M
| $454K | 0.01% |
10,940
| – | – |
|
|
CHK
750
DELISTED
Chesapeake Energy Corporation
CHK
| $451K | 0.01% |
+1,075
| New | +$740K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2018 Portfolio in Review
As of Q4 2018, Jacobs Levy Equity Management held 1,139 positions worth $5.69B, down 19% from $7.05B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Jacobs Levy Equity Management's Q4 2018 filing shows 165 new, 376 increased, 380 reduced and 175 closed positions. Its largest new stake was Starbucks: 930,980 shares worth $60M. The largest sale was Dell, an estimated $45.2M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q4 2018 buy was Starbucks: 930,980 shares worth $60M.
- Jacobs Levy Equity Management added most to Celgene Corp in Q4 2018, an estimated $27.6M increase.
- Jacobs Levy Equity Management's biggest Q4 2018 reduction was Accenture, cutting an estimated $24M.
- Jacobs Levy Equity Management fully exited Dell in Q4 2018, selling an estimated $45.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 18% of its $5.69B portfolio in Q4 2018.
- Jacobs Levy Equity Management opened 165 new positions and closed 175 in Q4 2018.
- Jacobs Levy Equity Management's portfolio value fell 19% quarter-over-quarter to $5.69B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2018, filed 14 Feb 2019.